1
Hepkema, Hiltsje, Pouwels, Koen B., van der Ende, Arie, Westra, Tjalke A., Postma, Maarten J.
Veröffentlicht in: Hepkema , H , Pouwels , K B , van der Ende , A , Westra , T A & Postma , M J 2013 , ' Meningococcal Serogroup A, C, W-135 and Y Conjugated Vaccine : A Cost-Effectiveness Analysis in the Netherlands ' , PLoS ONE , vol. 8 , no. 5 , e65036 . https://doi.org/10.1371/journal.pone.0065036;
2013
Veröffentlicht in: Hepkema , H , Pouwels , K B , van der Ende , A , Westra , T A & Postma , M J 2013 , ' Meningococcal Serogroup A, C, W-135 and Y Conjugated Vaccine : A Cost-Effectiveness Analysis in the Netherlands ' , PLoS ONE , vol. 8 , no. 5 , e65036 . https://doi.org/10.1371/journal.pone.0065036;
2013
2
de Vries, Robin, Kretzschmar, Mirjam, Schellekens, Joop F. P., Versteegh, Florens G. A., Westra, Tjalke A., Roord, John J., Postma, Maarten J.
Veröffentlicht in: de Vries , R , Kretzschmar , M , Schellekens , J F P , Versteegh , F G A , Westra , T A , Roord , J J & Postma , M J 2010 , ' Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands : Using an Individual-Based Dynamic Model ' , PLoS ONE , vol. 5 , no. 10 , 13392 . https://doi.org/10.1371/journal.pone.0013392;
2010
Veröffentlicht in: de Vries , R , Kretzschmar , M , Schellekens , J F P , Versteegh , F G A , Westra , T A , Roord , J J & Postma , M J 2010 , ' Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands : Using an Individual-Based Dynamic Model ' , PLoS ONE , vol. 5 , no. 10 , 13392 . https://doi.org/10.1371/journal.pone.0013392;
2010
3
Westra, Tjalke A., Stirbu-Wagner, Irina, Dorsman, Sara, Tutuhatunewa, Eric D., de Vrij, Edwin L., Nijman, Hans W., Daemen, Toos, Wilschut, Jan C., Postma, Maarten J.
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013